ALEC
Price
$5.39
Change
+$0.05 (+0.94%)
Updated
May 3, 6:59 PM EST
88 days until earnings call
BCRX
Price
$4.45
Change
-$0.03 (-0.67%)
Updated
May 3, 6:59 PM EST
One day until earnings call
Ad is loading...

Analysis and predictions ALEC vs BCRX

Header iconALEC vs BCRX Comparison
Open Charts ALEC vs BCRXBanner chart's image
Alector
Price$5.39
Change+$0.05 (+0.94%)
Volume$189.54K
CapitalizationN/A
BioCryst Pharmaceuticals
Price$4.45
Change-$0.03 (-0.67%)
Volume$1.71M
CapitalizationN/A
View a ticker or compare two or three
ALEC vs BCRX Comparison Chart

Loading...

ALECDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALEC vs. BCRX commentary
May 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and BCRX is a Hold.

COMPARISON
Comparison
May 05, 2024
Stock price -- (ALEC: $5.39 vs. BCRX: $4.45)
Brand notoriety: ALEC: Not notable vs. BCRX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 49% vs. BCRX: 84%
Market capitalization -- ALEC: $519.51M vs. BCRX: $918.17M
ALEC [@Biotechnology] is valued at $519.51M. BCRX’s [@Biotechnology] market capitalization is $918.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileBCRX’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • BCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCRX is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 5 TA indicator(s) are bullish while BCRX’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 5 bullish, 3 bearish.
  • BCRX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +2.67% price change this week, while BCRX (@Biotechnology) price change was +6.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

ALEC is expected to report earnings on Aug 01, 2024.

BCRX is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALEC with price predictions.
OPEN
A.I.dvisor published
a Summary for BCRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCRX($918M) has a higher market cap than ALEC($520M). BCRX YTD gains are higher at: -25.710 vs. ALEC (-32.456).
ALECBCRXALEC / BCRX
Capitalization520M918M57%
EBITDAN/AN/A-
Gain YTD-32.456-25.710126%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECBCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALECDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCSMX10.530.16
+1.54%
BCM FOCUS SMALL/Micro-Cap
CGEZX18.880.25
+1.34%
Columbia Select Global Equity Inst
LMTIX21.470.27
+1.27%
Franklin U.S. Large Cap Equity I
MXINX12.920.13
+1.02%
Empower International Index Inv
AGVHX22.390.18
+0.81%
American Funds Global Insight F-3

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+0.94%
DNLI - ALEC
50%
Loosely correlated
+1.96%
NTLA - ALEC
47%
Loosely correlated
+1.42%
NRIX - ALEC
46%
Loosely correlated
+0.39%
VERV - ALEC
43%
Loosely correlated
+4.23%
BCRX - ALEC
42%
Loosely correlated
-0.67%
More

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-0.67%
NTLA - BCRX
51%
Loosely correlated
+1.42%
FOLD - BCRX
47%
Loosely correlated
-0.29%
VCYT - BCRX
46%
Loosely correlated
+0.79%
XNCR - BCRX
46%
Loosely correlated
+2.03%
BEAM - BCRX
45%
Loosely correlated
+1.80%
More